ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
4,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
5,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
5,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
7,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7,2,Gastrointestinal tract irritation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
8,1,Brain neoplasm malignant,Central nervous system neoplasms malignant NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
8,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
9,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
9,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
9,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
10,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
10,3,Gastrointestinal tract irritation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
11,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
11,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
11,4,Lipase abnormal,Digestive enzymes,Gastrointestinal investigations,Inv,N
11,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11,6,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
11,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
13,1,Blood calcium abnormal,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
13,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
13,3,Hypercalcaemic nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,Y
13,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
14,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
15,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
16,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
17,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
18,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
18,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
19,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
19,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
20,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
21,1,Blood parathyroid hormone increased,Parathyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
22,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
23,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
23,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
23,3,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
24,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
24,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
25,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
25,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
26,1,Calciphylaxis,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
26,2,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
26,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
26,4,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
26,5,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
27,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
27,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
27,3,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
27,4,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
28,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
29,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
30,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
30,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
30,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
31,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
32,1,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
33,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
33,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
34,1,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
34,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
34,3,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
34,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
35,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
35,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
35,3,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
35,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
36,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
37,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
37,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
38,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
39,1,Blood calcium abnormal,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
39,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
40,1,Abdominal hernia,Abdominal hernias NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
40,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
40,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
40,4,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
40,5,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
40,6,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
40,7,Hepatic cyst,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
40,8,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
40,9,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
40,10,Peritoneal disorder,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
40,11,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
40,12,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
40,13,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
41,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
42,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
43,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
44,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
44,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
45,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
45,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
45,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
46,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
46,2,Pityriasis rosea,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
46,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
46,4,Rubber sensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
47,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
47,2,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
48,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
48,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
49,1,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
50,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
50,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
51,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
52,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
52,2,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
52,3,Cardiovascular insufficiency,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
52,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
52,5,Dyspnoea paroxysmal nocturnal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
52,6,Electrocardiogram QRS complex prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
52,7,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
52,8,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
52,9,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
52,10,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
53,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
53,2,Cerebral small vessel ischaemic disease,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
53,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
53,4,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
53,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
54,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
55,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
55,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
55,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
56,1,Calciphylaxis,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
57,1,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
57,2,Vitamin D deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
58,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
59,1,Calciphylaxis,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
59,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
60,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
60,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
60,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
60,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
60,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
60,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
61,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
61,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
62,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
62,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
62,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
62,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
63,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
63,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
64,1,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
65,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
66,1,Blood calcium abnormal,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
66,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
66,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
66,4,Parathyroid tumour malignant,Endocrine neoplasms malignant and unspecified NEC,Endocrine neoplasms malignant and unspecified,Neopl,Y
67,1,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
68,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
68,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
68,3,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
69,1,Calciphylaxis,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
70,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
70,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
71,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
72,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
72,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
72,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
73,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
74,1,Gastrostomy,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
75,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
75,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
75,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
76,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
76,2,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
76,3,Renal vein thrombosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
76,4,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
77,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
78,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
78,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
79,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
80,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
81,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
82,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
82,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
83,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
83,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
84,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
84,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
85,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
85,2,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
86,1,Blood parathyroid hormone increased,Parathyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
86,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
86,3,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
87,1,Gastrostomy,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
87,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
88,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
89,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
89,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
90,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
90,2,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
91,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
91,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
92,1,Gastrostomy,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
93,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,Y
93,2,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
93,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
93,4,Parathyroid disorder,Parathyroid disorders NEC,Parathyroid gland disorders,Endo,N
94,1,Blood parathyroid hormone decreased,Parathyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
94,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
95,1,Gastrostomy,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
96,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
97,1,Blood calcium abnormal,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
97,2,Blood parathyroid hormone abnormal,Parathyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
97,3,Renal transplant,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
98,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
98,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
98,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
98,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
98,5,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
98,6,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
99,1,Blood parathyroid hormone decreased,Parathyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
99,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
99,3,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
100,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
100,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
100,3,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
100,4,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
100,5,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
101,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
101,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
102,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
103,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
103,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
104,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
104,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
104,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
105,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
106,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
106,2,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
106,3,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
106,4,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
107,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
107,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
108,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
108,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
108,3,Gastrostomy,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
109,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
110,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
111,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
111,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
112,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
113,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
113,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
114,1,Gastrostomy,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
115,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
115,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
115,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
116,1,Infected skin ulcer,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
116,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
116,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
117,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
118,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
118,2,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
118,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
119,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
120,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
120,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
121,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
121,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
122,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
122,2,Gastrostomy,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
123,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
123,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
123,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
124,1,Gastrostomy,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
125,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
125,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
125,3,Neck exploration,"Head, neck and oral cavity therapeutic procedures NEC",Head and neck therapeutic procedures,Surg,N
125,4,Parathyroid disorder,Parathyroid disorders NEC,Parathyroid gland disorders,Endo,N
126,1,Blood parathyroid hormone decreased,Parathyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
127,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
127,2,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
128,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
129,1,Gastrostomy,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
130,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
130,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
130,3,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
131,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
132,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
132,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
133,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
134,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
134,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
135,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
135,2,Transplant,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
136,1,Gastrostomy,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
137,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
138,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
138,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
139,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
140,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
141,1,Gastrostomy,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
142,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
142,2,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
142,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
142,4,Delirium,Deliria,Deliria (incl confusion),Psych,N
142,5,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
142,6,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
143,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
144,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
144,2,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
145,1,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
145,2,Pelvic deformity,Trunk deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
145,3,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
146,1,Benign prostatic hyperplasia,Prostatic neoplasms and hypertrophy,Prostatic disorders (excl infections and inflammations),Repro,N
146,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
147,1,Brain hypoxia,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
147,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
148,1,Gastrostomy,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
149,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
150,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
150,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
150,3,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
151,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
152,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
152,2,Hungry bone syndrome,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
152,3,Parathyroid tumour benign,Endocrine neoplasms benign NEC,Endocrine neoplasms benign,Neopl,N
152,4,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
152,5,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
153,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
153,2,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
154,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
154,2,Endocrine disorder,Endocrine disorders NEC,Endocrine and glandular disorders NEC,Endo,N
155,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
155,2,Staring,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
155,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
156,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
157,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
158,1,Gastrostomy,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
158,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
159,1,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
160,1,Blood parathyroid hormone increased,Parathyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
160,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
160,3,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
160,4,Pathological fracture,Fractures NEC,Fractures,Musc,N
161,1,Blood parathyroid hormone increased,Parathyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
161,2,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
161,3,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
161,4,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
162,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
163,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
164,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
164,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
165,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
166,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
167,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
168,1,Parathyroidectomy,Parathyroid gland therapeutic procedures,Endocrine gland therapeutic procedures,Surg,N
169,1,Gastrostomy,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
169,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
170,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
170,2,Endocrine disorder,Endocrine disorders NEC,Endocrine and glandular disorders NEC,Endo,N
170,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
171,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
172,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,Y
173,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
173,2,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
173,3,Hypervigilance,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
173,4,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
174,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
175,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
175,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
175,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
175,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
176,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
177,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
177,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
178,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
178,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
179,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
179,2,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
179,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
179,4,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
179,5,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
180,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
181,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
182,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
182,2,Pancreatitis relapsing,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
182,3,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
183,1,Chapped lips,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
183,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
184,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
184,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
184,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
185,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
185,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
186,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
187,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
188,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
189,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
189,2,Headache,Headaches NEC,Headaches,Nerv,N
189,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
190,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
191,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
192,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
193,1,Blood parathyroid hormone increased,Parathyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
193,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
194,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
195,1,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
195,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
195,3,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
196,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
196,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
196,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
197,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
197,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
197,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
198,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
198,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
199,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
200,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
201,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
201,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
202,1,Procedural pain,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
202,2,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
203,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
204,1,Back disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
205,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
205,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
205,3,Headache,Headaches NEC,Headaches,Nerv,N
205,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
205,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
205,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
205,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
206,1,Chondrocalcinosis,Crystal arthropathic disorders,Joint disorders,Musc,N
207,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
207,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
207,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
207,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
207,5,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
207,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
208,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
209,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
210,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
211,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
211,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
211,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
212,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
212,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
212,3,Headache,Headaches NEC,Headaches,Nerv,N
212,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
212,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
213,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
213,2,Glucose-6-phosphate dehydrogenase deficiency,Inborn errors of carbohydrate metabolism (excl glucose),Metabolic and nutritional disorders congenital,Cong,N
214,1,Glucose-6-phosphate dehydrogenase deficiency,Inborn errors of carbohydrate metabolism (excl glucose),Metabolic and nutritional disorders congenital,Cong,N
215,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
216,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
216,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
216,3,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
216,4,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
216,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
217,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
217,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
218,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
219,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
220,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
220,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
221,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
222,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
223,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
224,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
225,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
225,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
225,3,Nephrocalcinosis,Renal lithiasis,Urolithiases,Renal,N
225,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
225,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
226,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
227,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
227,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
227,3,Headache,Headaches NEC,Headaches,Nerv,N
227,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
227,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
227,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
227,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
228,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
228,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
228,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
228,4,Hypercalcaemia of malignancy,Ectopic endocrine disorders,Neoplastic and ectopic endocrinopathies,Endo,N
228,5,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
228,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
228,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
228,8,Small cell lung cancer metastatic,Respiratory tract small cell carcinomas,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
228,9,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
228,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
229,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
230,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
231,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
232,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
232,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
233,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
234,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
235,1,Renal transplant,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
236,1,Parathyroid tumour benign,Endocrine neoplasms benign NEC,Endocrine neoplasms benign,Neopl,N
237,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
237,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
237,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
237,4,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
237,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
238,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
239,1,Beta haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
239,2,Calciphylaxis,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
239,3,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
239,4,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
239,5,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
239,6,Polyomavirus-associated nephropathy,Polyomavirus infections,Viral infectious disorders,Infec,N
239,7,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
239,8,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
239,9,Wound dehiscence,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
240,1,Beta haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
240,2,Calciphylaxis,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
240,3,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
240,4,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
240,5,Polyomavirus-associated nephropathy,Polyomavirus infections,Viral infectious disorders,Infec,N
240,6,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
240,7,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
240,8,Wound dehiscence,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
241,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
242,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
243,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
244,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
245,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
245,2,Parathyroid tumour benign,Endocrine neoplasms benign NEC,Endocrine neoplasms benign,Neopl,N
245,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
246,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
247,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
248,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
249,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
250,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
251,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
252,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
253,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
254,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
255,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
255,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
255,3,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
255,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
255,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
255,6,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
255,7,Vitamin D decreased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
256,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
257,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
258,1,Renal transplant,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
259,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
260,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
261,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
262,1,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
263,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
263,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
264,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
